Global Patent Index - EP 1222185 A1

EP 1222185 A1 20020717 - TETRAHYDROBENZINDOLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS 5-HT7 RECEPTOR ANTAGONISTS

Title (en)

TETRAHYDROBENZINDOLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS 5-HT7 RECEPTOR ANTAGONISTS

Title (de)

TETRAHYDROBENZINDOLON-DERIVATE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS 5-HT7 REZEPTOR ANTAGONISTEN

Title (fr)

DERIVES DE TETRAHYDROBENZYNEDOLONE, LEUR PREPARATION ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DES RECEPTEURS 5-HT 7

Publication

EP 1222185 A1 20020717 (EN)

Application

EP 00971384 A 20001013

Priority

  • EP 0010149 W 20001013
  • GB 9924628 A 19991018
  • GB 0006168 A 20000314
  • GB 0018952 A 20000803

Abstract (en)

[origin: WO0129029A1] The invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R<1> is halogen, C1-6alkyl, hydroxy, C1-6alkoxy, C1-6alkylthio, C1-6alkylsulphinyl, C1-6alkylsulphonyl, amino, mono- or di-C1-6alkylamino, carboxy, carboxamido, hydroxyC1-6alkyl, mono- or di-C1-6alkylaminocarbonyl, sulphonamido, C1-6alkylsulphonylamino, aminoC1-6alkyl, mono- or di-C1-6alkylaminosulphonyl or C1-6alkoxycarbonyl; R<2> is hydrogen, C1-6alkyl or arylC1-6alkyl; p is 0, 1, 2 or 3; R<3> is hydrogen or C1-6alkyl; n is 2, 3, 4, 5 or 6; A is nitrogen, carbon or CH, <o>.....</o>, is a single bond when A is nitrogen or CH or <o>.....</o> is a double bond when A is carbon; X is nitrogen or CH; Y is O, S, NH or N-C1-6alkyl, R<4> is halogen, C1-6alkyl, cyano, CF3, C3-7cycloalkyl, C1-6alkoxy, hydroxy, amino, mono- or di-C1-6alkylamino, acylamino, nitro, C1-6alkoxycarbonyl, C1-6alkylthio, C1-6alkylsulphinyl, C1-6alkylsulphonyl, sulphamoyl, mono- and di-C1-6alkylsulphamoyl, carbamoyl, mono- and di-C1-6alkylcarbamoyl, C1-6alkylsulphonamido, arylsulphonamido, aryl, arylC1-6alkyl, arylC1-6alkoxy, aryloxy and arylthio; m is 0, 1, 2 or 3, having 5-HT7 antagonist activity, processes for their preparation, to compositions containing them and to their use in the treatment of CNS and other disorders.

IPC 1-7

C07D 403/12; C07D 413/12; C07D 417/12; C07D 401/14; A61K 31/445; A61K 31/495; A61K 31/44; A61P 25/00

IPC 8 full level

A61K 31/4439 (2006.01); A61K 31/4535 (2006.01); A61K 31/454 (2006.01); A61K 31/496 (2006.01); A61P 25/00 (2006.01); A61P 25/06 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 43/00 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01)

CPC (source: EP)

A61P 25/00 (2017.12); A61P 25/06 (2017.12); A61P 25/20 (2017.12); A61P 25/22 (2017.12); A61P 25/24 (2017.12); A61P 43/00 (2017.12); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01)

Citation (search report)

See references of WO 0129029A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0129029 A1 20010426; AU 1025601 A 20010430; EP 1222185 A1 20020717; HK 1049151 A1 20030502; JP 2003512372 A 20030402

DOCDB simple family (application)

EP 0010149 W 20001013; AU 1025601 A 20001013; EP 00971384 A 20001013; HK 02109226 A 20021219; JP 2001531828 A 20001013